Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Ablative Solutions was founded in 2011 by David Fischell, Tim Fischell.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 39 based in Greater Boston Area.
Ablative Solutions may be growing as evidenced by the successful clinical trial outcomes of their renal denervation kit, which met its primary endpoint. This achievement is indicative of the company's progress in product development within the medical device sector. Additionally, the results from the TARGET BP I Pivotal Trial, which showed a significant reduction in 24-hour ambulatory blood pressure, suggest that the company's product is effective and could lead to increased adoption in the healthcare market.
“Ablative Solutions, Inc. is investigating alcohol-mediated renal denervation delivered using the Peregrine System™ Infusion Catheter to reduce blood pressure in patients with hypertension.” ablativesolutions.com
Ablative Solutions is a biotechnology company based in Greater Boston Area, with 11-50 employees, founded in 2011. Its founders are David Fischell and Tim Fischell and it has raised $201.8 million over 8 rounds.
11-50 employees · artbio.com
11-50 employees · 3bblackbio.com
11-50 employees · abanalitica.com
51-100 employees · abingdonhealth.com
51-100 employees · abeonatherapeutics.com
1-10 employees · activelifescientific.com
251-500 employees · advancepact.com
501-1,000 employees · apcerls.com
abacusdx.com
501-1,000 employees · accuray.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.